Results you can trust
Molecular Testing
Hereditary Cancer Genetics(CGx)
-
A test that helps identify people at increased risk for cancer due to hereditary factors
-
Clinicians can assess personal cancer risk, review potential risk factors, provide recommendations about appropriate prevention
-
Who Should Be Screened?
-
A personal history of cancer at a young age
-
One to two first or second degree relatives diagnosed with cancer before the age of 50
-
Relatives diagnosed with ovarian cancer
-
Relatives diagnosed with male breast cancer
-
BiogeneGx
Pharmacogenetics (PGx)
-
Pharmacogenetics testing test that tells you how your genes affect your body’s response to medications
-
Specifically for pain, psychiatric disorders, and cardiovascular diseases
-
Individuals should be tested if they have ever had a lack of symptom relief and adverse, unpleasant or intolerable response to their current medication
Parkinsons / Alzheimers / Dementia (PAD)
-
Genetic information will be help physicians making better treatment and management choices
-
Patients will have better understanding of the disorder by genetic and psychosocial counseling
-
Other potential benefits include research study enrollment and support programs for caregivers and patients
-
More than 50% increased risk seen in close relative of individuals with confirmed pathogenic mutations
-
Family screening can help in identifying genetic predisposition to start timely management